Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Partnership unites AI and single cell technology to ...
During the recent Covid-19 pandemic, the rate of serious illness and death was jarringly high in older populations. Why? Weakening immune systems — as we age, we become more vulnerable to infections, ...
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
SEATTLE & VIENNA, January 20, 2026--(BUSINESS WIRE)--Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune ...
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
Parse Biosciences and Graph Therapeutics (Graph) today announced a strategic partnership to create one of the largest and most comprehensive immune cell perturbation atlases. The collaboration will ...
Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas
The collaboration will leverage Graph's lab-in-the-loop platform with Parse's GigaLab to profile hundreds of millions of cells from patients with immune diseases under systematic perturbation, making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results